Global Kidney Transplant Market, by Type (Living Donor Transplant, Paired Kidney Transplant, and Deceased Donor Transplant), by Age (Children and Adults), by End Users (Hospitals & Clinics and Transplant Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 81,037 in 2021 and is expected to exhibit a CAGR of 3.1% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.

Key players operating in the market are focusing on receiving approvals and launches from regulatory authorities and this is expected to drive the market growth over the forecast period.

For instance, in September 2021, Sanofi, a global biopharmaceutical company focused on human health, entered into agreement with Kadmon Holdings, Inc., a biopharmaceutical organization that develops, and discovers the market transformative therapies. It supports Sanofi’s strategy to rise its core assets of general medicines.

Global Kidney Transplant Market – Impact of Coronavirus (Covid-19) Pandemic

COVID-19 outbreak was first reported on December 31, 2019, in Wuhan, China. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 260 million cases and 5.2 million deaths due to Coronavirus (COVID-19) were reported up till November 29, 2021, across the globe.

During COVID-19 pandemic, as per studies, decrease in transplant activity in all countries was noticed. As per compared to lung, liver, and heart transplantation, the kidney transplantation was most affected. The three organ transplant rate patterns identified were: countries with a sharp decrease in transplantation rate with a low COVID-19 related death rate; countries with a moderate decrease in transplantation rate with a moderate COVID-19 related death rate; and countries with a slight decrease in transplantation rate despite a high COVID-19 related death rate. The reduction in transplant activity was marked during the first three months of pandemic with losses after June 2020, and also reducing again in October to December, 2020.

Browse 20 Market Data Tables and 35 Figures spread through 195 Pages and in-depth TOC on “Kidney Transplant Market”- Global Forecast to 2028, by Type (Living Donor Transplant, Paired Kidney Transplant, and Deceased Donor Transplant), by Age (Children and Adults), by End Users (Hospitals & Clinics and Transplant Centers), and by Regions (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/kidney-transplant-market-4887

Key players operating in the market are focusing on adoption of inorganic growth strategies such as mergers, approvals, collaborations, and acquisitions in order to strengthen their position in the global market. For instance, in April 2021, the U.S. FDA approved Farxiga (Dapagliflozin) to decrease the chances of kidney function decline, kidney failure, and hospitalization for heart failure in adults with chronic kidney disease.

Key Takeaways of the Global Kidney Transplant Market

  • Global kidney transplant market is expected to exhibit a CAGR of 3.1% over the forecast period, owing to rising launches, and regulatory approvals of products. For instance, in September 2020, GlaxoSmithKline plc, a British multinational pharmaceutical company headquartered in London, England, announced that the U.S. Food and Drug Administration (FDA) had approved BENLYSTA for the treatment of adult patients with active lupus nephritis (a type of kidney disease caused bysystemic lupus erythematosus link). The most severe form of lupus can lead to end-stage kidney disease, which will require dialysis or kidney transplant.
  • Among type, living donor transplant is expected to account for largest market share during the forecast period. The living donor transplant is estimated to be valued at US$ 81,037 Mn in 2021 and is expected to register a CAGR of 3.1% and reach US$ 106,179 Mn by 2028.
  • Major players operating in the global kidney transplant market include Sanofi, Pfizer, Inc., Novartis AG., B. Braun Melsungen AG, Fresenius Medical Care, Medtronic, Preservation Solution Inc., TransMedics, Inc., Organ Recovery Systems, and Transonic Systems Inc.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo